Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.45B |
| 2 |
Apple
AAPL
|
+$814M |
| 3 |
NVIDIA
NVDA
|
+$700M |
| 4 |
Broadcom
AVGO
|
+$647M |
| 5 |
Shopify
SHOP
|
+$593M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$701M |
| 2 |
Johnson & Johnson
JNJ
|
+$685M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$484M |
| 4 |
Meta Platforms (Facebook)
META
|
+$407M |
| 5 |
HubSpot
HUBS
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.47% |
| 2 | Financials | 12.85% |
| 3 | Industrials | 11.86% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Healthcare | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
BioCryst Pharmaceuticals
BCRX
$2.53B
| $8.9M | ﹤0.01% |
993,117
+24,962
| +3% | +$232K |
|
1827
C3.ai
AI
$1.51B
| $8.89M | ﹤0.01% |
361,798
+39,708
| +12% | +$908K |
|
1828
Amphastar Pharmaceuticals
AMPH
$856M
| $8.88M | ﹤0.01% |
386,971
+27,828
| +8% | +$691K |
|
1829
Sweetgreen
SG
$705M
| $8.88M | ﹤0.01% |
596,755
-4,727,817
| -89% | -$77.9M |
|
1830
Consolidated Water Co
CWCO
$502M
| $8.88M | ﹤0.01% |
295,698
-10,590
| -3% | -$274K |
|
1831
CRA International
CRAI
$1.05B
| $8.86M | ﹤0.01% |
47,287
+15,015
| +47% | +$2.68M |
|
1832
NCR Atleos
NATL
$3.45B
| $8.84M | ﹤0.01% |
309,742
-22,348
| -7% | -$603K |
|
1833
Werner Enterprises
WERN
$2.31B
| $8.82M | ﹤0.01% |
322,272
-3,184
| -1% | -$87K |
|
1834
Structure Therapeutics
GPCR
$3.83B
| $8.81M | ﹤0.01% |
424,548
+30,162
| +8% | +$663K |
|
1835
Century Communities
CCS
$2.03B
| $8.79M | ﹤0.01% |
156,083
-69,999
| -31% | -$3.92M |
|
1836
Atlas Energy Solutions
AESI
$1.49B
| $8.78M | ﹤0.01% |
656,866
+31,966
| +5% | +$437K |
|
|
BRKL
1837
DELISTED
Brookline Bancorp
BRKL
| $8.77M | ﹤0.01% |
831,270
-104,623
| -11% | -$1.09M |
|
1838
National Healthcare
NHC
$3.48B
| $8.75M | ﹤0.01% |
81,777
-4,677
| -5% | -$467K |
|
1839
BlackSky Technology
BKSY
$1.25B
| $8.72M | ﹤0.01% |
423,845
+206,371
| +95% | +$2.22M |
|
|
WIW
1840
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$513M
| $8.72M | ﹤0.01% |
994,948
+7,860
| +0.8% | +$67.4K |
|
1841
Gildan
GIL
$10.5B
| $8.69M | ﹤0.01% |
176,535
+38,982
| +28% | +$1.79M |
|
1842
Gentherm
THRM
$1.28B
| $8.68M | ﹤0.01% |
306,825
+30,324
| +11% | +$805K |
|
1843
SITE Centers
SITC
$158M
| $8.68M | ﹤0.01% |
767,455
-1,436,128
| -65% | -$17.2M |
|
1844
Veracyte
VCYT
$3.52B
| $8.66M | ﹤0.01% |
320,563
+21,373
| +7% | +$619K |
|
1845
Dentsply Sirona
XRAY
$2.27B
| $8.65M | ﹤0.01% |
545,025
+21,708
| +4% | +$325K |
|
1846
Glacier Bancorp
GBCI
$6.47B
| $8.65M | ﹤0.01% |
200,808
-471,630
| -70% | -$19.5M |
|
1847
Rithm Capital
RITM
$5.75B
| $8.64M | ﹤0.01% |
765,572
-12,369
| -2% | -$136K |
|
1848
Eagle Bancorp
EGBN
$881M
| $8.62M | ﹤0.01% |
442,614
+58,212
| +15% | +$1.08M |
|
1849
Washington Trust Bancorp
WASH
$764M
| $8.61M | ﹤0.01% |
304,400
+8,938
| +3% | +$249K |
|
|
AAMI
1850
Acadian Asset Management
AAMI
$3.23B
| $8.61M | ﹤0.01% |
244,270
+70,700
| +41% | +$2.06M |
|
Similar funds
Invesco's Q2 2025 Portfolio in Review
As of Q2 2025, Invesco held 3,922 positions worth $588B, up 11% from $528B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Invesco's Q2 2025 filing shows 165 new, 1,670 increased, 1,835 reduced and 165 closed positions. Its largest new stake was QXO Inc: 27,561,664 shares worth $594M. The largest sale was UnitedHealth, an estimated $701M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q2 2025 buy was QXO Inc: 27,561,664 shares worth $594M.
- Invesco added most to Microsoft in Q2 2025, an estimated $1.45B increase.
- Invesco's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $701M.
- Invesco fully exited Discover Financial Services in Q2 2025, selling an estimated $484M.
- Invesco's ten largest holdings make up 20% of its $588B portfolio in Q2 2025.
- Invesco opened 165 new positions and closed 165 in Q2 2025.
- Invesco's portfolio value rose 11% quarter-over-quarter to $588B.
Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.